Disclaimer

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions



DO YOU WISH TO CONTINUE AND ENTER THIS WEBSITE?

SJM-CV WEB-0718-0009

/content/bss/divisionalsites/livesites/reusable/cv-livesite/us/en/pages/home
30
CARDIOVASCULAR
hamburger
BACK
Infiltrac

State-of-the-Art Tip Technology

Chronic total occlusions (CTOs) are prevalent, occurring in 20% of patients undergoing percutaneous coronary intervention (PCI),¹ even though these lesions are seriously undertreated.² Fortunately, successful PCIs for CTOs are steadily increasing—despite the increasing complexity of the lesions attempted—due in part to advances in guide wire technology.²

A penetration wire guide wire—the HI-TORQUE INFILTRAC™ Guide Wire, with its CTO indication—is key to successfully penetrating the CTO cap using the antegrade wire escalation (AWE) technique. The design of this specialized guide wire, including its enhanced technology and performance characteristics, all contribute to CTO procedural efficacy and efficiency.

The HI-TORQUE INFILTRAC guide wire, with CTO indication, successfully penetrates the CTO cap.

The HI-TORQUE INFILTRAC™ Guide Wire Designed for CTO Penetration

Micro-Textured Tip: For CTO Passage

This guide wire’s unique micro-textured tip:

  • Provides excellent traction*
  • Can penetrate even resistant proximal CTO caps†

Because the tip is uncoated, it also provides exceptional tactile feedback to the operator.†

The micro-textured tip surface design on the HI-TORQUE INFILTRAC guide wire enables penetration of resistant proximal CTO caps.

Tapered Tip: For High Penetration Capabilities

There are two penetration powers available with the HI-TORQUE INFILTRAC guide wire, used with the antegrade wire escalation technique.

  HI‑TORQUE INFILTRAC™ Guide Wire HI‑TORQUE INFILTRAC™ PLUS Guide Wire
Tip Load* 11 g 14 g
Penetration Power* 167 kg/in² 224 kg/in²

With either choice of guide wire, the tip is tapered to 0.009” to improve penetration capability. In addition to penetration power, the tapered, pre-shaped micro-J tip is a critical feature enabling CTO PCI success.

The HI-TORQUE INFILTRAC guide wires’ tapered tip enables excellent penetration: either 167 kg/in2 or 224 kg/in².


Pre-Shaped Micro-J Tip

The HI-TORQUE INFILTRAC™ Guide Wire’s micro-J tip has a 25° angle extending 1 mm from the tip. This enhances steering to help penetrate CTO lesions.†

The 25-degree angle on the HI-TORQUE INFILTRAC J-tip both aids in steering and enables CTO penetration.


Unique Guide Wire Design

Penetration of challenging CTOs is due to a number of unique design features of the HI-TORQUE INFILTRAC™ Guide Wire:

  • Micro-textured tip to engage the CTO cap*
  • Tapered, pre-shaped tip for high penetration*
  • Uncoated tip for tactile feedback†

Abbott’s proven guide wire design features are also incorporated into the design:

  • DURASTEEL stainless steel for needed support
  • Hydrophilic coating (excluding the tip) for lubricity and ease of movement within a microcatheter
  • Parabolic core grind for excellent torque response
The HI-TORQUE INFILTRAC guide wire incorporates unique features new to this guide wire, as well as proven features of other Abbott guide wires.

Ordering Information

Description non-CE** Part Number CE Part Number  Tip Load (g)* Penetration Power (kg/in²)* Wire Length (cm) Tip Diameter (in) Tip Shape
HI-TORQUE INFILTRAC™ Guide Wire 1030001J 1030005J 11 167 190 0.009 Micro-J
1030002J 1030006J 11 167 300 0.009 Micro-J
HI-TORQUE INFILTRAC™ PLUS Guide Wire 1030003J 1030007J 14 224 190 0.009 Micro-J
1030004J 1030008J 14 224 300 0.009 Micro-J

References

* Tests performed by and data on file at Abbott.
** Same as U.S. FDA part numbers applicable to select OUS countries
† Data on file at Abbott.

  1. Fefer P, Knudtson ML, Cheema AN, et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol. 2012;59(11):991-997.
  2. Konstantinidis NV, Werner GS, Deftereos S, et al, Euro CTO Club. Temporal Trends in Chronic Total Occlusion Interventions in Europe. Circ Cardiovasc Interv. 2018;11(10):e006229.

MAT-2104932 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

YESNO
accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

YESNO
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

YESNO